From: Exploring the potential of black tea based flavonoids against hyperlipidemia related disorders
Concentration (μg/mL) | % pancreatic inhibitory activity | Means | |||||
---|---|---|---|---|---|---|---|
TFW | TFM | TFE | TRW | TRM | TRE | ||
0 | 8 ± 0.05 | 12 ± 0.02 | 14 ± 0.84 | 6 ± 0.1 | 9 ± 0.3 | 11 ± 0.73 | 10.00 ± 0.06 g |
100 | 22 ± 1.6 | 26 ± 0.9 | 32 ± 1.2 | 15 ± 0.4 | 18 ± 0.6 | 24 ± 1.4 | 22.83 ± 0.89f |
200 | 36 ± 1.8 | 44 ± 1.5 | 52 ± 2.1 | 30 ± 0.4 | 32 ± 2.1 | 41 ± 2.1 | 39.17 ± 1.26e |
300 | 42 ± 1.2 | 52 ± 3.1 | 63 ± 2.5 | 35 ± 1.1 | 48 ± 2.6 | 52 ± 2.3 | 48.67 ± 2.26d |
400 | 50 ± 3.3 | 62 ± 2.7 | 72 ± 4.5 | 40 ± 2.5 | 52 ± 4.1 | 59 ± 2.8 | 55.83 ± 2.44c |
500 | 55 ± 2.9 | 78 ± 5.4 | 82 ± 3.7 | 49 ± 2.2 | 58 ± 3.7 | 65 ± 4.2 | 64.50 ± 4.53b |
600 | 65 ± 3.1 | 82 ± 4.5 | 91 ± 5.1 | 62 ± 4.5 | 75 ± 3.4 | 81 ± 6.7 | 76.00 ± 5.40a |
Means | 39.71 ± 1.26e | 50.86 ± 3.66b | 58.00 ± 4.36a | 33.86 ± 1.6f | 41.71 ± 2.58d | 47.57 ± 3.75c |  |